INTRODUCTION
============

Percutaneous coronary intervention (PCI) or balloon angioplasty alone (POBA = plain old balloon angioplasty) provides relief from angina pectoris in patients with single and multi-vessel coronary artery disease (CAD). Angiographic renarrowing at the site of a previous PCI is known as restenosis and occurs in approximately 30 - 50% of patients at 6 months after the procedure \[[@R1]\]. Restenosis after PCI/POBA is the major problem limiting long-term efficacy of this procedure. With the use of stents (a bare metal strut) delivered on an angioplasty balloon, the restenosis rate has been successfully lowered by roughly 10% (20 - 40% restenosis dependent upon the type of lesion and acuity) when compared to balloon angioplasty alone \[[@R2],[@R3]\]. The advent of drug eluting stents (DES) coated with agents that interfere with cellular proliferation (sirolimus or rapamycin and paclitaxel) has further reduced the restenosis rate to 10-15%, but episodes of acute late stent thrombosis have occurred with inadequate antiplatelet therapy or resistance to platelet inhibition. Currently, the DES has become one of the principal treatments for coronary artery stenosis, together with bare metal stents (BMS) both of which carry some risk of in stent restenosis (ISR) and/or sudden thrombosis \[[@R4]\]. Thus while improved, the problem of restenosis and/or thrombosis persists. Acute thrombotic events are postulated to be caused by a lack of adequate reendothelialization, protective cell covering of the metal stent struts embedded in the artery wall as well as inflammatory reactions to the metal and the DES polymer drug coating. Due to the inherent risk of ISR with the use of stents, POBA is used to alleviate ISR thus preventing two layers of stents. Despite the well-documented track record of reducing ISR using these procedures, it is important to continue investigating other means of treatment.

Although the typical restenotic lesion is different from the atherosclerotic plaque in architecture and composition, both restenotic and atherosclerotic plaques contain smooth muscle cells and fibrous tissue, as well as infiltrating inflammatory macrophages and T cells. After vascular injury is induced by PCI/ POBA, the activation of the inflammatory response is followed by intimal smooth muscle cell proliferation and migration, extracellular matrix formation and neointimal hyperplasia \[[@R5]\]. These events are initiated by both cellular and clot forming components of the blood, damaged vascular endothelial cells, connective tissue exposed by balloon denudation, and inflammatory cell mediators \[[@R6]\]. A critical stage in the development of restenosis is thought to be the activation of an inflammatory response, including platelet adhesion, platelet aggregation, fibrin (clot) deposition, and leukocyte infiltration \[[@R7]\]. This inflammatory response also involves enzymatic activation of serine protease activity and its subsequent regulation by serine protease inhibitors \[[@R8]\]. One of the serine protease inhibitors, plasminogen inhibitor-1 (PAI-1), has been demonstrated to play a significant role in suppression of intimal hyperplasia in some animal models \[[@R9]\]. PAI-1 knockout mice showed accelerated intimal hyperplasia as observed histologically \[[@R10],[@R11]\]. Similarly, inhibition of plasminogen with traexamic acid reduced smooth muscle cell migration following arterial balloon injury in rats \[[@R12]\]. Coagulation and fibrinolytic enzymes are known to induce monocyte motility, chemotaxis, tissue infiltration, cell proliferation, and apoptosis \[[@R8],[@R10],[@R11],[@R12]\]. The search for an agent that prevents restenosis after PCI still represents an important area of biomedical research. Anticoagulants, anti-platelet agents, calcium channel blockers, lipid-lowering agents, steroidal and non-steroidal anti-inflammatory drugs have all been unsuccessful in the prevention of restenosis \[[@R7]\].

Viruses have complicated lifestyles and have been used to develop many tools used in biological research. Lentiviruses, adenoviruses and retroviruses have all been genetically modified to exploit their gene transfer abilities and prevent neointimal hyperplasia in animal models \[[@R13],[@R14]\]. Large DNA viruses, especially poxviruses and herpesviruses, have a wide array of strategies to modulate and/or evade host immune and inflammatory responses \[[@R13],[@R15]\]. A previous study using attenuated herpes simplex virus 1 mutant R7020, was capable of significantly reducing neointimal hyperplasia in New Zealand White rabbits receiving balloon angioplasty \[[@R16]\]. Myxoma virus, a poxvirus, encodes a viral anti-inflammatory protein called M-T7 \[[@R17]\]. This protein is capable of mimicking the IFN-γ receptor and binds to a variety of human, rabbit and mouse C, C-C, and CXC chemokines \[[@R18]\]. A study using purified M-T7 protein revealed reduced macrophage invasion due to the inhibition of chemokines in both rats and rabbits receiving vascular injury \[[@R15]\]. The myxoma virus also encodes a secretory serine protease inhibitor (termed Serp-1) that upon infection inhibits serine proteases such as plasminogen \[[@R19],[@R20]\]. An earlier study \[[@R21]\] has demonstrated the effect of the Serp-1 glycoprotein on neointimal hyperplasia after balloon angioplasty in rabbits, showing a significant reduction in neointimal formation and macrophage invasion. A different myxoma virus protein called Serp-2 is a cross-class serpin that is present inside virus-infected cells. In rats, Serp-2 has been shown to significantly reduce plaque size at the site of angioplastic injury \[[@R22]\].

As an extension to the M-T7, Serp-1 and Serp-2 studies from myxoma virus, we decided to evaluate whether a systemic poxvirus infection could induce sufficient host-immune modulation and/or suppression to elicit antiproliferative effects in a large animal model of restenosis. The porcine model was utilized due to the fact that the neointimal lesion that results after balloon-induced vascular injury is composed of smooth muscle and inflammatory cells, similar to that observed in human patients. Additionally, a species specific poxvirus is available to evaluate these observations. This was a critical issue as most of the known natural immunomodulators, including cytokines, are mainly species specific. This experimental model appears to be very useful in spite of the fact that neither swine cytokines nor swinepox virus (SPV) secretory proteins are well-characterized. In this report we demonstrate that the systemic poxvirus infection induces sufficient host immunosuppression and/or modulation to elicit an antiproliferative effect in a large animal model of neointimal hyperplasia.

MATERIALS AND METHODOLOGY
=========================

Animals and Diet
----------------

Female and male domestic feeder pigs (Yorkshire-Hampshire-Landrace-Duroc crosses, 2-3 months old) were provided from Pharmacia & Upjohn Farms and fed on S-985 chow (18% crude protein, Pharmacia & Upjohn feed) until the PCI/POBA procedure. After PCI/ POBA, the animals were fed S-810-L chow (16% crude protein, including 200 gm/ton of the antibiotic lincomycin; Pharmacia & Upjohn feed) throughout the rest of the study. The investigation conforms to the Guide for the Care and Use of the laboratory Animals published by the US National Institutes of Health.

SPV Production and Infection Procedures
---------------------------------------

SPV was obtained from American Type Culture Collection (VR-363, Rockville, Maryland) and cultivated in monolayers of Porcine Kidney 15 (PK-15) cells. PK-15 cells were grown in RPMI 1640 medium containing 10 % (v/v) newborn calf serum (NBCS), 2mM glutamine and antibiotics (100 units/ml penicillin G sodium, 100 mg/ml streptomycin sulfate, and 0.25mg/ml amphotericin B) (Growth Medium). Cells were cultured at 37°C in an incubator with 5% CO2. Infected cells were harvested 7-8 days post-infection and the virus was concentrated and quantitated using established procedures for tanapox virus \[[@R23]\]. The concentrated virus was stored at -70° C. Mock infected cells were processed in an identical manner. One week prior to the angioplasty balloon (POBA) over-inflation procedure, 20.0 ml venous blood sample was taken *via*superior vena cava venipuncture and the animals were segregated to separate holding rooms according to treatment to minimize the possibility of cross-infection. Animals were subsequently injected subcutaneously with either 1 x 10^8^ plaque forming units (PFU) of SPV, or mock-infected cells in the right inguinal fold. A second blood sample was collected 3 weeks following balloon angioplasty. The serum collected was used to detect anti-SPV antibodies.

Percutaneous Transluminal Coronary Balloon Angioplasty (PCI/ POBA)
------------------------------------------------------------------

All animal surgical protocols were performed according to local and national guidelines for animal care and were approved by the local IACUC animal committee (Pharmacia & Upjohn) prior to the performance of the studies. The POBA procedure intentionally over-stretches a 2.0 cm segment of porcine left anterior descending (LAD) coronary artery and has been previously described in detail \[[@R24]\]. All POBA procedures were performed under general anesthetic with ketamine/midazolam (recommended dose per kg) and the pigs were intubated for the procedure. Catheters were introduced *via*the right carotid artery exposed by cutdown and advanced retrograde to the left coronary ostium and then into the LAD. Immediately before coronary arterial advancement of a PCI catheter, a 50 mg intravenous (i.v.) dose of the antifibrillatory, antiarrhythmic agent, bretylium tosylate was given and an intracoronary injection of nitroglycerin (50 to 150 μg) to alleviate post-PCI vasospasm. Heparin was also administered as a bolus of 200 U/kg, i.v. followed by an i.v. infusion of 50 U/kg/hr. Aspirin was dissolved and administered i.v. at a dose of 5.0 mg/kg. A GE-mobile X-ray (fluoroscope) connected to a video cassette recorder was used to locate the balloon visually and to record angiograms throughout the PCI procedure. After each procedure, these angiograms were replayed on a 12 inch monitor to calculate over-inflation ratio (OI ratio), which denoted the diameter ratio of the inflated balloon catheter (3.0 or 3.5 mm PCI catheter inflated with contrast dye) to the diameter ratio of the original coronary arterial site subjected to PCI. Throughout all PCI procedures, attempts were made to overstretch a 2.0 cm segment of LAD coronary artery between 30% and 50% (OI ratio = 1.3 - 1.5). This level of overstretch has previously been shown to reproducibly elicit a neointimal proliferative response in the artery without causing thrombotic complications or vasospasm of the vessel \[[@R24]\]. Overstretch was applied twice in 60 second intervals with each inflation lasting 20 seconds at 8 atmospheres. After all surgical devices were removed and incision points surgically repaired, effectiveness of the POBA was confirmed by a repeat angiogram. At the end of the procedure, each pig was administered penicillin G procaine intramuscularly (1.5 million units) and recovered in their cages over 2 to 3 hours post-procedure. Post-angioplasty treatment for 2 weeks consisted solely of daily aspirin at an oral dose of 80 mg/kg.

Histopathology and Morphometric Analysis of Porcine LAD Coronary Artery
-----------------------------------------------------------------------

Two weeks following the PCI/POBA procedure, pigs were anesthetized with ketamine/midazolam which was administered intramuscularly. The external jugular vein was surgically exposed to gain catheter access. Heparin (200 U/kg) was administered systemically followed by Evan\'s blue dye (1% v/v in physiological saline) to delineate the lesion site at the LAD coronary artery. Evan\'s blue dye is excluded by intact endothelium indicative of the lesion site and thus was allowed to circulate in the pig for 1 hour prior to induction of euthanasia with Socumb (\>50 mg/kg sodium pentobarbital i.v.). Immediately after death, the hearts were removed and retrogradely perfused at 100 mmHg with physiological saline for 15 minutes. The hearts were then perfused with Omni-fix II fixative (An-Con Genetics, Inc., Melville, NY) for 30 minutes. Three consecutive 1.0 cm LAD segments (two regions of altered Evan\'s blue dye uptake, 1 region of proximal or distal uninvolved coronary artery) were taken from each balloon injured site then fixed in Omni-Fix II fixative for more than 24 hours for subsequent paraffin embedding. Ten cross-sections were made throughout the entire length of each of the three sample segments. The sections were stained with aldehyde fuschin and counter stained with Van Giesson\'s solution to differentiate the internal elastic lamina (IEL). On the 30 cross-sectioned coronary arteries (20 sections from the Evan\'s blue stained 2.0 cm segment; 10 sections from the 1.0 cm segment showing no Evan\'s blue stain), morphometric measurements were performed with a computer aided image analysis system (The Microscope CO., Medina, OH). The degree of vascular injury induced by POBA balloon over-inflation and the degree of neointimal hyperplasia was determined by previously established methods \[[@R24]\]. It has been previously demonstrated that the extent of IEL rupture corresponds directly with the magnitude of the neointimal hyperplastic response \[[@R24]\], therefore it was important to quantify both parameters in each cross-section. The extent of vessel injury was quantified as the injury index of each cross-section. This was calculated as the percentage of the internal elastic lamina that fractured due to balloon injury, divided by the entire circumference of the lamina. The resultant magnitude of the neointimal proliferative response was quantitated as the proliferation index, which was calculated as the ratio of the area of the neointimal lesion (NI) to the total area of the medial layer (M) for each cross-section. The values of the injury and proliferative indices from each cross-section taken from the sections of the same balloon-injured site were averaged to yield one value for each animal.

RESULTS
=======

Mortality and Exclusions
------------------------

Within a group of 22 pigs, 19 pigs survived the two week recovery period after POBA balloon-induced over-inflation. Two of the SPV infected pigs died from lethal arrhythmia due to acute POBA failure with arterial thrombotic occlusion. One control pig died from respiratory failure during post PCI recovery. From the 19 surviving pigs, 2 pigs (1 control and 1 SPV infected) were excluded from analysis because they developed abnormal double-lumen morphology at the balloon-injured site. Also, one SPV infected pig was excluded from analysis due to an unusually large injury index In total, data from 8 control and 8 infected pigs were utilized to examine effects of SPV infection on restenosis.

Symptomology in Swine
---------------------

Since poxviruses cause visible skin lesions on their hosts, symptoms on pigs were carefully examined for verification of SPV infection. Pigs infected with live SPV developed a lesion at the site of subcutaneous injection within one week post-infection. However, by three weeks post-infection, only 2 out of 8 SPV-infected pigs exhibited escalated skin lesions throughout the groin and the axillary regions (results not shown). It must be noted that 3 of the 8 mock-infected pigs developed rashes similar to SPV-infected pigs throughout their inguinal areas, suggesting the possibility of existing disease in the animal population (which is known to be endemic); or there could have been cross-contamination at the facility even though the groups were carefully segregated. Thus, the data was analyzed two ways. The first subset compared two groups: the 8 mock-infected control pigs and versus the 8 SPV-infected pigs. The second subset consisted of the 5 control pigs and 11 infected pigs. This subset accounts for an observation that 3 control pigs developed SPV-like symptoms 21 days post mock infection. The 3 pigs with SPV symptoms were transferred from control group to infected group.

Morphometric Analysis of Swine LAD Coronary Arteries: Subset I
--------------------------------------------------------------

In order to assess the effects of SPV infection on neointimal hyperplasia, cross-sections of balloon-injured porcine LAD coronary arteries were morphologically compared in mock-infected control pigs (n=8) *vs* SPV-infected animals (n=8) at 2 weeks post-balloon induced arterial injury. Table **[1](#T1){ref-type="table"}** subset I demonstrates that the acute magnitude of balloon-induced arterial overstretch (over-inflation ratio) was similar for both control and infected pigs at approximately 40% overstretch of the vessel. The injury index was found to be similar in both control and infected pigs as expected due to similar degrees of balloon over-inflation. However, the neointimal area, which develops at the internal elastic fracture site in the 2 week period following balloon-induced arterial injury, was 23% larger (but not statistically significant) in control pigs compared to infected pigs. The medial and external elastic lamina areas were similar indicating that the overall vessel sizes were similar in both groups of animals. To control for any possible differences in size of the vessels under study, the proliferation index was routinely calculated by the NI/M ratio mentioned earlier. In control pigs the NI/M ratio was 1.04, which suggests that the neointima developed an area over a 2 week period roughly similar to that of the existing medial area of the vessel. However in SPV-infected pigs, the NI/M ratio was reduced to 0.85 which represents a 22% reduction (p=0.08, ANOVA).

A typical cross-section from a control mock-infected pig is shown in Fig. (**[1a](#F1){ref-type="fig"}**). This animal had a NI/M ratio of 1.11 which was similar to the group mean of 1.04. Fig. (**[1b](#F1){ref-type="fig"}**) represents a typical cross section from a SPV-infected pig with a NI/M ratio of 0.88 which was similar to the group mean of 0.85. Note in both Fig. (**[1a](#F1){ref-type="fig"}**, **[b](#F1){ref-type="fig"}**) that the neointimal area which develops as a consequence of balloon-induced overstretch of the vessel, occurs between the flaps of the ruptured internal elastic lamina.

Subset II
---------

As indicated previously, 3 control pigs developed SPV symptoms as indicated by skin lesions in the inguinal areas. Thus, for analysis purposes, these 3 pigs were grouped with the previous 8 SPV infected pigs and removed from the control group such that the control group presented now consisted of only 5 pigs and the SPV group consisted of 11 pigs. These data are demonstrated in Table **[1](#T1){ref-type="table"}**, subset II. As seen previously in subset I, the degree of balloon overstretch and injury index is similar in both groups as indicated by similar over-inflation ratios of approximately 40% and injury indices of 25-26%. However, the neointimal area is decreased by 27% in infected pigs compared to control animals. Furthermore, the medial and external elastic laminar areas are similar such that the NI/M ratio reflects a correspondingly statistically significant reduction of 33% (p=0.05).

DISCUSSION
==========

Initiation of neointimal proliferation following PCI/ POBA involves activation of inflammatory and thrombotic cascades, which are commonly regulated by serine protease enzymes and inhibitors \[[@R8]\]. Inflammatory cascades result in the adhesion of leukocytes, induced by cytokine-leukocyte signaling. Many poxviruses encode proteins which inhibit or bind to host cytokines. Those proteins are known as immunomodulatory proteins. Myxoma virus produces serine protease inhibitors (Serp-1 and Serp-2) that upon infection inhibits serine proteases such as plasminogen and granzyme B \[[@R19],[@R20]\]. Local introduction of purified immunomodulatory proteins encoded by vaccinia virus and myxoma virus has been reported to inhibit neointimal hyperplasia induced by vascular injury \[[@R21],[@R22]\]. In our study, based on the idea that all poxviruses secrete some sort of immunomodulatory polypeptides upon infection, an SPV systemic infection was assumed to secrete similar polypeptides. Since these SPV encoded polypeptides have not been characterized, we used systemic SPV infection on domestic feeder pigs to determine if SPV induced immunosuppression could cause an antiproliferative effect in a porcine model of injury-induced neointimal proliferation which mimics restenosis in humans.

In order to determine the degree of neointimal proliferation, at three weeks post-infection with either vehicle or SPV, pig LAD coronary arteries were harvested and morphologically examined. Subcutaneous administration of SPV to domestic feeder pigs a week prior to POBA balloon over-inflation reduced neointimal hyperplasia by 23% compared to mock-infected pigs. When the NI/M ratio was calculated, the magnitude of neointimal proliferation was 22% lower in the SPV-infected group compared to the mock-infected group (Table **[1](#T1){ref-type="table"}**), however this data did not reach statistical significance.

As mentioned previously, 3 out of 8 control pigs developed skin rashes throughout the inguinal region, which resembled swinepox infection. Since swinepox is an endemic disease among swine populations, there is the possibility that those control pigs were cross contaminated or infected before the experiment. Thus, re-analysis of the data in which the 3 control pigs presenting with typical SPV-like infection are included in the SPV group. This generated a further reduction in the NI/M ratio for the SPV-infected pigs compared to control pigs, representing a 33% reduction which reached statistical significance, despite the relatively small population sizes.

The unavailability of reproducible immunological techniques to demonstrate anti-SPV neutralizing antibodies and T cells severely restricted our ability to evaluate experimental SPV infections in pigs. It also restricted our ability to demonstrate whether some pigs were previously immune to SPV infections. Our efforts to establish a reproducible procedure to quantitate anti-SPV neutralizing antibodies were unsuccessful. These observations further confirmed earlier results from some leading SPV laboratories in the U.S. (Richard Moyer and Deoki Tripathy, personal communications). It is not clear if whether SPV itself or the pig immune system contributes to this limitation. However, we were able to confirm active SPV infection based on symptomology and anti-viral antibody detection in serum in all 11 pigs analyzed in subset II. Meanwhile, the 5 control pigs in subset II did not show any evidence of SPV infection using these techniques.

Like the myxoma virus serine protease inhibitor (serpin) Serp-2 that has been shown to reduce inflammatory cell invasion and plaque growth in rodent angioplastic injury models, SPV also encodes a similar serpin called SPV 145R or K1R \[[@R22],[@R25],[@R26]\]. The SPV145R has a high level of homology with the cowpox virus serpin/crmA homologue. The crmA protein from cowpox virus has been shown to inhibit the cellular IL-1β converting enzyme, modulating inflammation and apoptosis \[[@R27]\]. On a different note, the SPV 008 encodes a protein that shares 25% sequence homology the myxoma virus MT-7 protein \[[@R25]\]. The myxoma virus MT-7 protein is an IFN-γ viroceptor and multiple chemokine binding protein, that has been shown to display anti-inflammatory properties in rat and rabbit vascular injury models \[[@R15],[@R17]\]. In addition to the proteins mentioned here, SPV encodes many more immunomodulating proteins that could possibly control inflammation during a systemic infection and therefore reduce neointimal hyperplasia.

CONCLUSION
==========

We have shown that a systemic infection of swinepox is capable of alleviating neointimal hyperplasia induced by angioplastic vascular injury. Although the actual proteins and mechanisms responsible for these observations are unknown, it suggests that a systemic infection of a poxvirus is capable of generating therapeutic effects for its host. Additional experiments knocking out selected SPV genes potentially involved in immunomodulation will precisely identify proteins which participate, either directly or indirectly, in the suppression of neointimal hyperplasia in pigs.
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![Representative cross section of a LAD coronary artery from control/mock and SPV infected pigs. The arrowheads represent rupture sites made by the balloon over-inflation. These areas between arrowheads show neointimal cell proliferation, which is a main characteristic of the restenosis. Notice that degree of the neointimal cell proliferation in SPV-infected pig (**a**) differs from that of mock infected pigs (**b**). NI/M of SPV infected pigs = 0.88, NI/M of mock infected pigs = 1.11.](TOVJ-6-91_F1){#F1}
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Morphological Analysis of Balloon-Injured Porcine Coronary Artery Segments Harvested 2 Weeks After Intentional PCI Over-Inflation

  ----------------------------- --------------------------- ----------------------------------------------------------------------- --------------------------------------------- ----------------------------- ----------------------------------------------------- ---------------------------------------------
  **Subset I**                                                                                                                                                                                                                                                        
  **Group**                     **Over-Inflation Ratio**    **Injury Index ([1](#T1F1){ref-type="table-fn"}IEL~f~ /IELc x100)**     **Neointimal Area (NI) (mm^2^)**              **Medial Area (M) (mm^2^)**   **[2](#T1F2){ref-type="table-fn"}EEL Area (mm^2^)**   **Proliferation Index (NI/M)**
  Control (Mock Infected) n=8   1.43 ± 0.01                 25.9 ± 2.3                                                              0.49 ± 0.07                                   0.50 ± 0.03                   2.82 ± 0.14                                           1.04 ± 0.16
  SPV Infected n=8              1.41 ± 0.02                 25.7 ± 3. 7                                                             0.40 ± 0.04                                   0.48 ± 0.02                   2.80 ± 0.10                                           0.85 ± 0.09
  **Subset II**                                                                                                                                                                                                                                                       
  **Group**                     **Over -Inflation Ratio**   **Injury Index ([1](#T1F1){ref-type="table-fn"}IEL~f~ /IEL~c~ x100)**   **Neointimal Area(NI) (mm^2^)**               **Medial Area (M) (mm^2^)**   **[2](#T1F2){ref-type="table-fn"}EEL Area (mm^2^)**   **Proliferation Index (NI/M)**
  Control (Mock Infected) n=5   1.42 ± 0.02                 26.5 ± 1.9                                                              0.52 ± 0.03                                   0.48 ± 0.03                   2.74 ± 0.20                                           1.14 ± 0.12
  SPV Infected n=11             1.44 ± 0.02                 25.43 ± 3.0                                                             0.41 ± 0.06[\*](#T1F3){ref-type="table-fn"}   0.49 ± 0.02                   2.83 ± 0.10                                           0.86 ± 0.11[\*](#T1F2){ref-type="table-fn"}
  ----------------------------- --------------------------- ----------------------------------------------------------------------- --------------------------------------------- ----------------------------- ----------------------------------------------------- ---------------------------------------------

Internal Elastic Lamina (IEL~f~ = IEL fracture length, IEL~C~ = IEL circumference).

External Elastic Lamina.

p = 0.05 *vs* control.
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